Author Correction: ATR inhibition augments the efficacy of lurbinectedin in small-cell lung cancer

Abstract

Correction to: EMBO Molecular Medicine (2023) 15:e17313. 10.15252/emmm.202217313 | Published online 25 July 2023

By mutual agreement of all authors and by the evidence that the additional author meets the appropriate authorship criteria, Laura L Bassel and their contribution and authorship position will be added to this manuscript.

The authorship will be corrected from:

Christopher W Schultz¹, Yang Zhang¹, Rajaa Elmeskini², Astrid Zimmermann³, Haiqing Fu¹, Yasuhisa Murai¹, Darawalee Wangsa⁴, Suresh Kumar¹, Nobuyuki Takahashi^1,5, Devon Atkinson², Liton Kumar Saha¹, Chien-Fei Lee⁶, Brian Elenbaas⁶, Parth Desai¹, Robin Sebastian¹, Ajit Kumar Sharma¹, Melissa Abel¹, Brett Schroeder¹, Manan Krishnamurthy¹, Rajesh Kumar¹, Nitin Roper¹, Mirit Aladjem¹, Frank T Zenke³, Zoe Weaver Ohler², Yves Pommier¹, Anish Thomas¹

To:

Christopher W Schultz¹, Yang Zhang¹, Rajaa Elmeskini², Astrid Zimmermann³, Haiqing Fu¹, Yasuhisa Murai¹, Darawalee Wangsa⁴, Suresh Kumar¹, Nobuyuki Takahashi^1,5, Devon Atkinson², Liton Kumar Saha¹, Chien-Fei Lee⁶, Brian Elenbaas⁶, Parth Desai¹, Robin Sebastian¹, Ajit Kumar Sharma¹, Melissa Abel¹, Brett Schroeder¹, Manan Krishnamurthy¹, Laurel L Bassel², Rajesh Kumar¹, Nitin Roper¹, Mirit Aladjem¹, Frank T Zenke³, Zoe Weaver Ohler², Yves Pommier¹, Anish Thomas¹

Author Statement:

Laura L Bassel, pathologist at the Center for Advanced Preclinical Research, Leidos Biomedical Research, Inc, Frederick National Laboratory for Cancer Research, Frederick, MD, USA, contributed to the above cited paper by quantifying the IHC stain and necrosis in (panel E in emmm202217313-fig-0005ev): Reference figure: emmm202217313-fig-0005ev-m.jpg-EMBO Molecular Medecine 2023.jpg.